1. Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
    Sara Elena Rebuzzi et al, 2023, Cancers CrossRef
  2. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
    Xumeng Gong et al, 2023, Front. Oncol. CrossRef
  3. Biological function, regulatory mechanism, and clinical application of mannose in cancer
    Haoyi Jin et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  4. OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer
    Zhong Yu et al, 2023, Discov Onc CrossRef
  5. Design strategies for enhancing antitumor efficacy through tumor microenvironment exploitation using albumin-based nanosystems: A review
    Cai Zhang et al, 2023, International Journal of Biological Macromolecules CrossRef
  6. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma
    Hualan Hong et al, 2024, Biomed Rep CrossRef
  7. Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
    Fabio Catalano et al, 2024, Future Oncology CrossRef
  8. A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era
    Anca-Narcisa Neagu et al, 2024, IJMS CrossRef
  9. Identification of an 11-miRNA-regulated and surface-protein genes signature predicts the prognosis of lung adenocarcinoma based on multi-omics study
    Kunyu Guo, 2024, Am J Transl Res CrossRef
  10. Overview of cancer: Mechanisms of carcinogenesis
    Uttara Saran et al, 2024 CrossRef
  11. NF-κB signaling pathway in tumor microenvironment
    Yaning Cao et al, 2024, Front. Immunol. CrossRef
  12. Immune Response and Tumor Microenvironment
    Vivek Pazhamalai et al, 2025 CrossRef
  13. Generation and banking of patient-derived glioblastoma organoid and its application in cancer neuroscience
    Li Zhou, 2024, Am J Cancer Res CrossRef
  14. Physiological markers for immunotherapeutics: a review
    Durlav Chowdhury et al, 2024, Journal of Chemotherapy CrossRef
  15. Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy
    Qixuan Feng et al, 2025, Front. Oncol. CrossRef
  16. Theoretical evaluation of the biological activity of hydrogen
    Grace Russell, 2025 CrossRef
  17. Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
    Feng Hao et al, 2025, J Ovarian Res CrossRef
  18. Regulatory role of PPAR in colorectal cancer
    Cong Wang et al, 2025, Cell Death Discov. CrossRef